Asensus Surgical Analyst Ratings
Asensus Surgical Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/15/2023 | 788.49% | HC Wainwright & Co. | → $2 | Reiterates | Buy → Buy |
| 08/22/2023 | 344.25% | Cantor Fitzgerald | → $1 | Reiterates | Overweight → Overweight |
| 08/11/2023 | 788.49% | HC Wainwright & Co. | → $2 | Reiterates | Buy → Buy |
| 05/12/2023 | 788.49% | HC Wainwright & Co. | → $2 | Reiterates | Buy → Buy |
| 03/06/2023 | 788.49% | HC Wainwright & Co. | $3 → $2 | Maintains | Buy |
| 02/22/2023 | 1232.74% | HC Wainwright & Co. | → $3 | Reiterates | → Buy |
| 01/10/2023 | 1232.74% | HC Wainwright & Co. | → $3 | Reiterates | → Buy |
| 09/08/2022 | 566.37% | Cantor Fitzgerald | → $1.5 | Initiates Coverage On | → Overweight |
| 08/10/2022 | 1232.74% | HC Wainwright & Co. | $4 → $3 | Maintains | Buy |
| 05/26/2021 | 1676.99% | HC Wainwright & Co. | → $4 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目标价格变动 | 评级变动 | 之前/当前的评级 |
|---|---|---|---|---|---|
| 11/15/2023 | 788.49% | HC Wainwright & Co. | → 2 美元 | 重申 | 购买 → 购买 |
| 08/22/2023 | 344.25% | 坎托·菲茨杰拉德 | → 1 美元 | 重申 | 超重 → 超重 |
| 08/11/2023 | 788.49% | HC Wainwright & Co. | → 2 美元 | 重申 | 购买 → 购买 |
| 05/12/2023 | 788.49% | HC Wainwright & Co. | → 2 美元 | 重申 | 购买 → 购买 |
| 03/06/2023 | 788.49% | HC Wainwright & Co. | 3 美元 → 2 美元 | 维护 | 买 |
| 02/22/2023 | 1232.74% | HC Wainwright & Co. | → 3 美元 | 重申 | → 购买 |
| 01/10/2023 | 1232.74% | HC Wainwright & Co. | → 3 美元 | 重申 | → 购买 |
| 09/08/2022 | 566.37% | 坎托·菲茨杰拉德 | → 1.5 美元 | 启动覆盖范围开启 | → 超重 |
| 08/10/2022 | 1232.74% | HC Wainwright & Co. | 4 美元 → 3 美元 | 维护 | 买 |
| 2021 年 5 月 26 日 | 1676.99% | HC Wainwright & Co. | → 4 美元 | 启动覆盖范围开启 | → 购买 |
What is the target price for Asensus Surgical (ASXC)?
Asensus Surgical (ASXC) 的目标价格是多少？
The latest price target for Asensus Surgical (AMEX: ASXC) was reported by HC Wainwright & Co. on November 15, 2023. The analyst firm set a price target for $2.00 expecting ASXC to rise to within 12 months (a possible 788.49% upside). 7 analyst firms have reported ratings in the last year.
HC Wainwright & Co. 于2023年11月15日公布了Asensus Surgical（美国证券交易所股票代码：ASXC）的最新目标股价。该分析公司将目标股价定为2.00美元，预计澳大利亚证券交易所将在12个月内升至12个月内（可能上涨788.49％）。去年有7家分析公司公布了评级。
What is the most recent analyst rating for Asensus Surgical (ASXC)?
分析师对Asensus Surgical（ASXC）的最新评级是多少？
The latest analyst rating for Asensus Surgical (AMEX: ASXC) was provided by HC Wainwright & Co., and Asensus Surgical reiterated their buy rating.
Asensus Surgical（美国证券交易所股票代码：ASXC）的最新分析师评级由HC Wainwright & Co. 提供，Asensus Surgical 重申了他们的买入评级。
When is the next analyst rating going to be posted or updated for Asensus Surgical (ASXC)?
Asensus Surgical（ASXC）的下一个分析师评级何时公布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Asensus Surgical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Asensus Surgical was filed on November 15, 2023 so you should expect the next rating to be made available sometime around November 15, 2024.
分析师在进行了广泛的研究后得出了股票评级，其中包括浏览公开财务报表，与Asensus Surgical的高管和客户交谈，以及听取财报电话会议。大多数分析师每三个月做一次这样的评级，因此每家公司每年应该获得4次评级。Asensus Surgical的最新评级是在2023年11月15日发布的，因此您应该预计下一个评级将在2024年11月15日左右公布。
Is the Analyst Rating Asensus Surgical (ASXC) correct?
分析师对Asensus Surgical (ASXC) 的评级是否正确？
While ratings are subjective and will change, the latest Asensus Surgical (ASXC) rating was a reiterated with a price target of $0.00 to $2.00. The current price Asensus Surgical (ASXC) is trading at is $0.23, which is within the analyst's predicted range.
尽管评级是主观的，并且会发生变化，但重申了最新的Asensus Surgical（ASXC）评级，目标股价为0.00美元至2.00美元。Asensus Surgical（ASXC）目前的交易价格为0.23美元，在分析师的预测区间内。